Gamma Frequency Stimulation in Individuals With Down Syndrome
RecruitingNCT05196984Phase: NAStarted 2021-12-06
Summary
Down Syndrome (DS) is characterized by an additional copy of chromosome 21, which also increases risk of Alzheimer's Disease (AD). The investigators' lab found a non-invasive way to remove toxic prote
Eligibility
Sex
ALL
Min Age
25 Years
Max Age
65 Years
Locations
Massachusetts Institute of TechnologyCambridge, Massachusetts, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT05196984